BASEL, Switzerland,
Sept. 6, 2017 /PRNewswire/
-- Axovant Sciences (NYSE: AXON) today announced upcoming
presentations by David Hung, M.D.,
chief executive officer of Axovant, on September 6, 2017 at 12:50
p.m. ET at the Baird 2017 Global Healthcare Conference, and
on September 12, 2017 at 10:35 a.m. ET at the Morgan Stanley Global
Healthcare Conference.
A simultaneous webcast will be available for each conference in
the Investors section of Axovant's website at www.axovant.com. A
replay will be available for 30 days following each conference.
About Axovant Sciences
Axovant is a clinical-stage
biopharmaceutical company focused on developing and commercializing
innovative medicines to broadly address multiple forms of dementia
and related neurological disorders. Axovant has a pipeline of late-
and early-stage product candidates that focuses on the cognitive,
functional, and behavioral aspects of debilitating conditions such
as Alzheimer's disease and Lewy body dementia and other
neurological disorders. For more information, visit
www.axovant.com.
Contacts:
Investors
Jonathan
Neely
jonathan.neely@axovant.com
Media
Samina Bari
samina.bari@axovant.com
View original
content:http://www.prnewswire.com/news-releases/axovant-to-present-at-two-upcoming-investor-conferences-300514408.html
SOURCE Axovant Sciences Ltd.